| Stage | BKNG | % of rev | RXO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $8.9B | 100.00% | $1.9B | 100.00% | BKNG ×4.75 |
| Gross profit | $8.9B | 100.00% | $333M | 17.80% | BKNG +82.2pp |
| Operating income | $3.4B | 38.43% | $17M | 0.91% | BKNG +37.5pp |
| Pre-tax income | $3.4B | 38.49% | $6M | 0.32% | BKNG +38.2pp |
| Net income | $2.7B | 30.55% | $3M | 0.16% | BKNG +30.4pp |
| Stage | BKNG | RXO | Gap · A − B |
|---|---|---|---|
| Revenue | $8.9B100.00% | $1.9B100.00% | BKNG ×4.75 |
| Gross profit | 100.00%$8.9B | 17.80%$333M | BKNG +82.2pp |
| Operating income | 38.43%$3.4B | 0.91%$17M | BKNG +37.5pp |
| Pre-tax income | 38.49%$3.4B | 0.32%$6M | BKNG +38.2pp |
| Net income |
| 30.55%$2.7B |
| 0.16%$3M |
| BKNG +30.4pp |